✦ LIBER ✦

Tamoxifen lacks efficacy in receptor negative breast cancer

Book ID: 120851680
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2006
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200615190-00039

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of UFT plus Tamoxifen for Estro

Efficacy of UFT plus Tamoxifen for Estrogen-Receptor-Positive Breast Cancer and Tamoxifen plus UFT for Estrogen-Receptor-Negative Breast Cancer

✍ Dr Masami Ogita, Junichi Uchino, Kazuaki Asaishi, Yoshihiko Kubo, Tatsuzo Tanabe 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 129 KB

Tamoxifen lacks efficacy in ductal carci

Tamoxifen lacks efficacy in ductal carcinoma in situ

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 150 KB

Tamoxifen stimulates in vivo growth of d

Tamoxifen stimulates in vivo growth of drug-resistant estrogen receptor-negative breast cancer

✍ Juhani Maenpaa; Valerie Wiebe; Steven Koester; Gregory Wurz; Vernon Emshoff; Rob 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 300 KB

Wnt-5a signaling restores tamoxifen sens

Wnt-5a signaling restores tamoxifen sensitivity in estrogen receptor-negative breast cancer cells

✍ Munshi, A. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 58 KB

HER2 overexpression and activation, and

HER2 overexpression and activation, and tamoxifen efficacy in receptor-positive early breast cancer

✍ Christian F. Singer; Daphne Gschwantler-Kaulich; Anneliese Fink-Retter; Georg Pf 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 362 KB

Tamoxifen efficacy in breast cancer affe

Tamoxifen efficacy in breast cancer affected by CYP2 genotype

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB